Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabolism modulation" refers to therapeutic approaches aimed at altering cellular metabolic pathways to treat disease, rather than a singular molecular target. Such modulation can shift energy substrate preference (e.g., from fatty acids to glucose in heart failure), interfere with cancer cell metabolism, or correct metabolic imbalances in metabolic disorders. Approaches and drugs termed "metabolic modulators" typically achieve their effects by inhibiting or activating key enzymes or regulatory checkpoints in metabolic pathways, and have been investigated in diverse contexts including cancer therapy, heart failure, and metabolic diseases[2][5]. This entry should not be treated as a specific molecular target but as an overarching strategy or therapeutic principle[2][5].
Inhibition or activation of enzymes involved in metabolism (e.g., fatty acid oxidation inhibitors, glycolysis modulators); Shifting substrate utilization (e.g., increasing glucose metabolism, reducing fatty acid oxidation)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabolism modulation.